Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-21-020542

Options or other derivatives

  • CFO acquired 0 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Raines Heather · CFO

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-08-16 Grant or award : show line 1 in the form 8% Unsecured Convertible Promissory Note due 2022 +0 $200,000.00 $0 D
Loading xslF345X03/ownership.xml…